Patents by Inventor Karel Kranda

Karel Kranda has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20110124600
    Abstract: Disclosed is the oral use of dopamine partial agonists and the physiologically acceptable salts thereof in order to create a pharmaceutical preparation for treating the restless legs syndrome, which effectively controls the symptoms while having a significantly smaller undesired effect of a medicament than medicaments known in prior art.
    Type: Application
    Filed: June 13, 2003
    Publication date: May 26, 2011
    Inventors: Karel Kranda, Reinhard Horwski, Karel Sonka, Johannes Tack
  • Patent number: 7622476
    Abstract: This invention relates to 1-allyl ergot alkaloids and their derivatives with selective antagonistic properties to 5-HT2 receptors for the prevention of, and relief from, migraine-related headache, Parkinson's disease, disorders of the thrombocyte function, etc.
    Type: Grant
    Filed: December 21, 2002
    Date of Patent: November 24, 2009
    Assignee: Axxonis Pharma AG
    Inventors: Miroslav Flieger, Heinz Pertz, Karel Kranda, Jan Cvak, Sven Jaenichen, Erika Glusa
  • Publication number: 20060014774
    Abstract: This invention relates to 1-allyl ergot alkaloids and their derivatives with selective antagonistic properties to 5-HT2 receptors for the prevention of, and relief from, migraine-related headache, Parkinson's disease, disorders of the thrombocyte function, etc.
    Type: Application
    Filed: December 21, 2002
    Publication date: January 19, 2006
    Inventors: Miroslav Flieger, Heinz Pertz, Karel Kranda, Jan Cvak, Sven Jachnichen, Erika Glusa